From Yahoo Finance: 2025-05-30 00:47:00

Bio-Techne Corporation (TECH) has a bullish thesis, trading at $47.93 with a trailing P/E of 57.75 and forward P/E of 22.03. The company has a diverse business in recombinant proteins and diagnostics, with about 56% of revenue from core legacy products. Despite setbacks, recent signs point to recovery with organic growth rebounding to 9%.

Around half of Bio-Techne’s revenue comes from commercial R&D, dominated by smaller biotechs. The company is gaining ground in GMP protein production and expanding into proteomics and spatial biology. Despite recent setbacks causing a nearly 50% stock price decline, Bio-Techne is focused on protecting core franchises while expanding into new growth areas.

Bio-Techne Corporation (TECH) is not among the 30 Most Popular Stocks Among Hedge Funds, with 34 hedge fund portfolios holding TECH. While the company has potential, some AI stocks may offer greater promise for higher returns in a shorter timeframe. If you are looking for a more promising AI stock trading at less than 5 times its earnings, check out our report on the cheapest AI stock.



Read more at Yahoo Finance: Bio-Techne Corporation (TECH): A Bull Case Theory